Galera Therapeutics Inc (GRTX)
0.1869
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 10:38
Galera Therapeutics Cash from Operations (TTM): -44.85M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -44.85M |
| September 30, 2023 | -48.88M |
| June 30, 2023 | -45.57M |
| March 31, 2023 | -43.71M |
| December 31, 2022 | -43.43M |
| September 30, 2022 | -46.93M |
| June 30, 2022 | -56.12M |
| March 31, 2022 | -64.04M |
| December 31, 2021 | -67.96M |
| Date | Value |
|---|---|
| September 30, 2021 | -66.96M |
| June 30, 2021 | -63.84M |
| March 31, 2021 | -62.45M |
| December 31, 2020 | -59.54M |
| September 30, 2020 | -58.36M |
| June 30, 2020 | -55.98M |
| March 31, 2020 | -50.12M |
| December 31, 2019 | -46.66M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-67.96M
Minimum
Dec 2021
-43.43M
Maximum
Dec 2022
-54.43M
Average
-55.98M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Ampio Pharmaceuticals Inc | -8.564M |